当前位置:
X-MOL 学术
›
Nat. Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
CAR macrophages on a fast track to solid tumor therapy
Nature Immunology ( IF 27.7 ) Pub Date : 2024-01-02 , DOI: 10.1038/s41590-023-01696-7 Shifaa M Abdin 1, 2 , Daniela Paasch 1, 2 , Nico Lachmann 1, 2, 3, 4, 5
Nature Immunology ( IF 27.7 ) Pub Date : 2024-01-02 , DOI: 10.1038/s41590-023-01696-7 Shifaa M Abdin 1, 2 , Daniela Paasch 1, 2 , Nico Lachmann 1, 2, 3, 4, 5
Affiliation
Expressing chimeric antigen receptors (CARs) in macrophages has led to promising results in preclinical and clinical work. Now, induced pluripotent stem cells have been combined with a second-generation CAR to achieve macrophage rewiring and to broaden the applicability of the approach to solid malignancies.
中文翻译:
CAR巨噬细胞进入实体瘤治疗快车道
在巨噬细胞中表达嵌合抗原受体(CAR)在临床前和临床工作中取得了有希望的结果。现在,诱导多能干细胞已与第二代 CAR 相结合,以实现巨噬细胞重新布线并扩大该方法对实体恶性肿瘤的适用性。
更新日期:2024-01-02
中文翻译:
CAR巨噬细胞进入实体瘤治疗快车道
在巨噬细胞中表达嵌合抗原受体(CAR)在临床前和临床工作中取得了有希望的结果。现在,诱导多能干细胞已与第二代 CAR 相结合,以实现巨噬细胞重新布线并扩大该方法对实体恶性肿瘤的适用性。